Literature DB >> 16574293

Improvement of tardive dyskinesia following amisulpride treatment.

Vaios Peritogiannis1, Sofia Tsouli, Spiros Zafiris, Dimitrios Pappas, Venetsanos Mavreas.   

Abstract

Tardive dyskinesia (TD) is a persistent, disturbing side effect of antipsychotic drug treatment. It is established that clozapine and other second generation agents cause less TD and may also improve pre-existing TD. We report a case of significant improvement of TD after the administration of amisulpride, a potential D(2)/D(3) antagonist that has atypical properties. The possible effect of fast dissociation of D(2) receptors is being discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574293     DOI: 10.1016/j.pnpbp.2006.01.022

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  2 in total

1.  Treatment of tardive dyskinesia with aripiprazole.

Authors:  Ricardo S Osorio; L Agüera-Ortiz; A Hurtado de Mendoza; I Ramos; T Palomo
Journal:  Neurotox Res       Date:  2009-10-14       Impact factor: 3.911

2.  Amisulpride Reexposure and Tardive Dyskinesia.

Authors:  Ajeet Sidana
Journal:  Indian J Psychol Med       Date:  2018 Jan-Feb
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.